Latest On Gossamer Bio, Inc (GOSS):
About Gossamer Bio, Inc (GOSS):
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It is developing GB001, an oral antagonist of prostaglandin D2 receptor 2, which is in Phase IIb clinical trial for the treatment of moderate-to-severe eosinophilic asthma; in Phase II clinical trial to treat patients with chronic rhinosinusitis with and without nasal polyps; and in Phase 2 clinical trial in patients with chronic spontaneous urticarial. The company is also developing GB002, an orally inhaled, small molecule, platelet-derived growth factor receptor kinase inhibitor in Phase Ib clinical trial for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule in Phase Ib clinical trial for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; and GB1275, an oral, small molecule, CD11b modulator in Phase 1/2 clinical trial for the treatment of selected solid tumor types. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
General
- Name Gossamer Bio, Inc
- Symbol GOSS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 195
- Fiscal Year EndDecember
- IPO Date2019-02-08
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.gossamerbio.com
Valuation
- Price/Book (Most Recent Quarter) 2.51
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$3.17
- Next Year EPS Estimate -$3.11
- Next Quarter EPS Estimate -$0.77
- Return on Assets -27%
- Return on Equity -72%
- Earnings Per Share -$5.95
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 749.23 million
- EBITDA -159303008
- Analyst Target Price $21.13
- Book Value Per Share $4.55
Share Statistics
- Shares Outstanding 75.53 million
- Shares Float 48.42 million
- % Held by Insiders 1105%
- % Held by Institutions 85.07%
- Shares Short 7.88 million
- Shares Short Prior Month 7.65 million
- Short Ratio 10.71
- Short % of Float 13%
- Short % of Shares Outstanding 10%
Technicals
- Beta 1.28
- 52 Week High $16.79
- 52 Week Low $7.92
- 50 Day Moving Average 10.23
- 200 Day Moving Average 10.5
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Gossamer Bio, Inc (GOSS) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Gossamer Bio, Inc (GOSS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-25 | $N/A | -$0.88 | -$0.79 | -11.68% |
2020-09-30 | 2020-11-10 | $N/A | -$0.80 | -$0.84 | 5.21% |
2020-06-30 | 2020-08-11 | $N/A | -$1.00 | -$0.82 | -21.65% |
2020-03-31 | 2020-05-12 | $N/A | -$0.87 | -$0.75 | -16% |
2019-12-31 | 2020-03-24 | $N/A | -$0.89 | -$0.82 | -8.8% |
2019-09-30 | 2019-11-12 | $N/A | -$0.80 | -$0.70 | -15.11% |
2019-06-30 | 2019-08-08 | $N/A | -$0.74 | -$0.56 | -32.14% |
2019-03-31 | 2019-05-14 | $N/A | -$0.90 | -$0.66 | -37.4% |
2018-12-31 | 2019-03-22 | $N/A | -$1.39 | -$1.37 | -1.46% |
Gossamer Bio, Inc (GOSS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Gossamer Bio, Inc (GOSS) Chart:
Gossamer Bio, Inc (GOSS) News:
Below you will find a list of latest news for Gossamer Bio, Inc (GOSS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Gossamer Bio, Inc (GOSS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-04-19 | 0.5 | 0.8 | CALL | 0 | 100 | 352.73 | TRUE | 0 | 0 |
2024-04-19 | 1 | 0.36 | CALL | 0 | 77 | 112.61 | TRUE | 0 | 0 |
2024-04-19 | 1.5 | 0.13 | CALL | 0 | 962 | 0 | FALSE | 0 | 0 |
2024-04-19 | 2 | 0.05 | CALL | 0 | 46 | 0 | FALSE | 0 | 0 |
2024-04-19 | 3 | 0.05 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-04-19 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 1 | 0.1 | PUT | 0 | 500 | 0 | FALSE | 0 | 0 |
2024-04-19 | 1.5 | 0.39 | PUT | 3 | 54 | 141.07 | TRUE | 0.39 | 0 |
2024-04-19 | 2 | 0.8 | PUT | 1 | 0 | 545.4 | TRUE | 0.8 | 0 |
2024-04-19 | 3 | 0 | PUT | 0 | 0 | 421.9 | TRUE | 0 | 0 |
2024-04-19 | 4 | 0 | PUT | 0 | 0 | 374.91 | TRUE | 0 | 0 |
2024-04-19 | 5 | 0 | PUT | 0 | 0 | 333.28 | TRUE | 0 | 0 |
2024-05-17 | 0.5 | 0 | CALL | 0 | 0 | 231.52 | TRUE | 0 | 0 |
2024-05-17 | 1 | 0.27 | CALL | 60 | 343 | 105.12 | TRUE | 0.27 | 0 |
2024-05-17 | 1.5 | 0.21 | CALL | 0 | 98 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2 | 0.1 | CALL | 0 | 284 | 0 | FALSE | 0 | 0 |
2024-05-17 | 3 | 0.04 | CALL | 0 | 30 | 0 | FALSE | 0 | 0 |
2024-05-17 | 4 | 0.1 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
2024-05-17 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 0.5 | 0 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
2024-05-17 | 1 | 0.1 | PUT | 0 | 54 | 110.12 | FALSE | 0 | 0 |
2024-05-17 | 1.5 | 0.3 | PUT | 0 | 15 | 85.92 | TRUE | 0 | 0 |
2024-05-17 | 2 | 0 | PUT | 0 | 0 | 365.21 | TRUE | 0 | 0 |
2024-05-17 | 3 | 0 | PUT | 0 | 0 | 194.95 | TRUE | 0 | 0 |
2024-05-17 | 4 | 0 | PUT | 0 | 0 | 256.58 | TRUE | 0 | 0 |
2024-05-17 | 5 | 0 | PUT | 0 | 0 | 419.64 | TRUE | 0 | 0 |
2024-08-16 | 0.5 | 1 | CALL | 0 | 3 | 199.25 | TRUE | 0 | 0 |
2024-08-16 | 1 | 0.54 | CALL | 0 | 42 | 113.23 | TRUE | 0 | 0 |
2024-08-16 | 1.5 | 0.3 | CALL | 0 | 24 | 128.28 | FALSE | 0 | 0 |
2024-08-16 | 2 | 0.2 | CALL | 0 | 146 | 250.34 | FALSE | 0 | 0 |
2024-08-16 | 3 | 0.05 | CALL | 0 | 17 | 0 | FALSE | 0 | 0 |
2024-08-16 | 4 | 0 | CALL | 0 | 11 | 0 | FALSE | 0 | 0 |
2024-08-16 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-08-16 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-08-16 | 1 | 0.19 | PUT | 0 | 23 | 119.12 | FALSE | 0 | 0 |
2024-08-16 | 1.5 | 0.5 | PUT | 0 | 5 | 135.72 | TRUE | 0 | 0 |
2024-08-16 | 2 | 0.75 | PUT | 0 | 5 | 117.66 | TRUE | 0 | 0 |
2024-08-16 | 3 | 0 | PUT | 0 | 0 | 168.82 | TRUE | 0 | 0 |
2024-08-16 | 4 | 0 | PUT | 0 | 0 | 164.77 | TRUE | 0 | 0 |
2024-08-16 | 5 | 0 | PUT | 0 | 0 | 184.83 | TRUE | 0 | 0 |
2024-11-15 | 0.5 | 0 | CALL | 0 | 0 | 256.03 | TRUE | 0 | 0 |
2024-11-15 | 1 | 0.66 | CALL | 0 | 25 | 127.97 | TRUE | 0 | 0 |
2024-11-15 | 1.5 | 0 | CALL | 0 | 0 | 119.26 | FALSE | 0 | 0 |
2024-11-15 | 2 | 0.36 | CALL | 0 | 5 | 124.55 | FALSE | 0 | 0 |
2024-11-15 | 3 | 0 | CALL | 0 | 0 | 119.81 | FALSE | 0 | 0 |
2024-11-15 | 4 | 0.2 | CALL | 0 | 1 | 121.66 | FALSE | 0 | 0 |
2024-11-15 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-11-15 | 1 | 0 | PUT | 0 | 0 | 145.25 | FALSE | 0 | 0 |
2024-11-15 | 1.5 | 0 | PUT | 0 | 0 | 122.47 | TRUE | 0 | 0 |
2024-11-15 | 2 | 0 | PUT | 0 | 0 | 123.42 | TRUE | 0 | 0 |
2024-11-15 | 3 | 0 | PUT | 0 | 0 | 137.2 | TRUE | 0 | 0 |
2024-11-15 | 4 | 0 | PUT | 0 | 0 | 167.42 | TRUE | 0 | 0 |
2025-01-17 | 0.5 | 0.7 | CALL | 10 | 170 | 61.31 | TRUE | 0.7 | 0 |
2025-01-17 | 1 | 0.74 | CALL | 0 | 720 | 279.97 | TRUE | 0 | 0 |
2025-01-17 | 1.5 | 0.45 | CALL | 0 | 1435 | 237.31 | FALSE | 0 | 0 |
2025-01-17 | 2 | 0.3 | CALL | 3 | 2359 | 115.74 | FALSE | -0.05 | -0.14 |
2025-01-17 | 2.5 | 0.34 | CALL | 0 | 390 | 125.26 | FALSE | 0 | 0 |
2025-01-17 | 3 | 0.4 | CALL | 0 | 425 | 142.84 | FALSE | 0 | 0 |
2025-01-17 | 3.5 | 0.22 | CALL | 0 | 155 | 121.26 | FALSE | 0 | 0 |
2025-01-17 | 4 | 0.15 | CALL | 0 | 33 | 0 | FALSE | 0 | 0 |
2025-01-17 | 4.5 | 0.12 | CALL | 0 | 31 | 0 | FALSE | 0 | 0 |
2025-01-17 | 5 | 0.15 | CALL | 0 | 115 | 0 | FALSE | 0 | 0 |
2025-01-17 | 5.5 | 0.05 | CALL | 0 | 21 | 0 | FALSE | 0 | 0 |
2025-01-17 | 0.5 | 0.1 | PUT | 0 | 2665 | 0 | FALSE | 0 | 0 |
2025-01-17 | 1 | 0.43 | PUT | 0 | 5725 | 146.33 | FALSE | 0 | 0 |
2025-01-17 | 1.5 | 0.82 | PUT | 0 | 11 | 122.98 | TRUE | 0 | 0 |
2025-01-17 | 2 | 0.97 | PUT | 0 | 11 | 136.01 | TRUE | 0 | 0 |
2025-01-17 | 2.5 | 0 | PUT | 0 | 26 | 123.74 | TRUE | 0 | 0 |
2025-01-17 | 3 | 0 | PUT | 0 | 0 | 131.35 | TRUE | 0 | 0 |
2025-01-17 | 3.5 | 0 | PUT | 0 | 0 | 155.37 | TRUE | 0 | 0 |
2025-01-17 | 4 | 0 | PUT | 0 | 0 | 146.13 | TRUE | 0 | 0 |
2025-01-17 | 4.5 | 0 | PUT | 0 | 0 | 173.91 | TRUE | 0 | 0 |
2025-01-17 | 5 | 0 | PUT | 0 | 0 | 168.87 | TRUE | 0 | 0 |
2025-01-17 | 5.5 | 0 | PUT | 0 | 0 | 162.26 | TRUE | 0 | 0 |
2026-01-16 | 0.5 | 1.15 | CALL | 0 | 29 | 173.57 | TRUE | 0 | 0 |
2026-01-16 | 1 | 0.75 | CALL | 0 | 353 | 271.83 | TRUE | 0 | 0 |
2026-01-16 | 1.5 | 0.65 | CALL | 0 | 10 | 122.26 | FALSE | 0 | 0 |
2026-01-16 | 2 | 0.58 | CALL | 0 | 953 | 157.28 | FALSE | 0 | 0 |
2026-01-16 | 3 | 0.46 | CALL | 0 | 1485 | 148.29 | FALSE | 0 | 0 |
2026-01-16 | 4 | 0.25 | CALL | 2 | 0 | 97.04 | FALSE | 0.25 | 0 |
2026-01-16 | 5 | 0.5 | CALL | 0 | 11 | 129.36 | FALSE | 0 | 0 |
2026-01-16 | 0.5 | 0 | PUT | 0 | 0 | 140.45 | FALSE | 0 | 0 |
2026-01-16 | 1 | 0 | PUT | 0 | 16 | 140.47 | FALSE | 0 | 0 |
2026-01-16 | 1.5 | 0.8 | PUT | 0 | 11 | 166.97 | TRUE | 0 | 0 |
2026-01-16 | 2 | 0.87 | PUT | 0 | 20 | 155 | TRUE | 0 | 0 |
2026-01-16 | 3 | 0 | PUT | 0 | 0 | 149.79 | TRUE | 0 | 0 |
2026-01-16 | 4 | 0 | PUT | 0 | 0 | 162.81 | TRUE | 0 | 0 |
2026-01-16 | 5 | 0 | PUT | 0 | 0 | 153.8 | TRUE | 0 | 0 |
Latest GOSS Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 11 | $6.14 |
Jun 13, 2022 7:59 PM EST | 65 | $6.14 |
Jun 13, 2022 7:59 PM EST | 100 | $6.13 |
Jun 13, 2022 7:59 PM EST | 100 | $6.13 |
Jun 13, 2022 7:59 PM EST | 21 | $6.13 |
Gossamer Bio, Inc (GOSS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459020031695/0001564590-20-031695-index.htm |
2018-11-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1728117/000000000018034960/0000000000-18-034960-index.htm |
2018-12-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1728117/000000000018038081/0000000000-18-038081-index.htm |
2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1728117/000083423720008084/0000834237-20-008084-index.htm |
2020-06-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1728117/000083423720009573/0000834237-20-009573-index.htm |
2019-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023148/0000899243-19-023148-index.htm |
2019-09-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023516/0000899243-19-023516-index.htm |
2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023857/0000899243-19-023857-index.htm |
2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000089924319024045/0000899243-19-024045-index.htm |
2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1728117/000090266420001197/0000902664-20-001197-index.htm |
2018-10-11 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1728117/000095012318009836/0000950123-18-009836-index.htm |
2018-11-29 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1728117/000095012318012230/0000950123-18-012230-index.htm |
2018-11-29 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1728117/000095012318012232/0000950123-18-012232-index.htm |
2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1728117/000107261320000101/0001072613-20-000101-index.htm |
2020-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1728117/000110465920016410/0001104659-20-016410-index.htm |
2018-08-01 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1728117/000114036118034679/0001140361-18-034679-index.htm |
2018-12-21 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1728117/000119312518356444/0001193125-18-356444-index.htm |
2018-12-21 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1728117/000119312518356460/0001193125-18-356460-index.htm |
2018-12-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1728117/000119312518358086/0001193125-18-358086-index.htm |
2019-01-23 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1728117/000119312519014857/0001193125-19-014857-index.htm |
2019-01-24 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1728117/000119312519015073/0001193125-19-015073-index.htm |
2019-01-30 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1728117/000119312519022653/0001193125-19-022653-index.htm |
2019-01-30 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1728117/000119312519022709/0001193125-19-022709-index.htm |
2019-02-04 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1728117/000119312519026953/0001193125-19-026953-index.htm |
2019-02-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1728117/000119312519028275/0001193125-19-028275-index.htm |
2019-02-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1728117/000119312519028283/0001193125-19-028283-index.htm |
2019-02-07 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1728117/000119312519031054/0001193125-19-031054-index.htm |
2019-02-08 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1728117/000119312519032320/0001193125-19-032320-index.htm |
2019-02-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1728117/000119312519032341/0001193125-19-032341-index.htm |
2019-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000119312519035980/0001193125-19-035980-index.htm |
2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1728117/000119312520037460/0001193125-20-037460-index.htm |
2020-05-18 | 305B2 | Filing [Trust Indenture Act] | https://www.sec.gov/Archives/edgar/data/1728117/000119312520145062/0001193125-20-145062-index.htm |
2020-05-18 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1728117/000119312520145156/0001193125-20-145156-index.htm |
2020-05-19 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1728117/000119312520145487/0001193125-20-145487-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008262/0001209191-19-008262-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008269/0001209191-19-008269-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008272/0001209191-19-008272-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008274/0001209191-19-008274-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008278/0001209191-19-008278-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008280/0001209191-19-008280-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008281/0001209191-19-008281-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008282/0001209191-19-008282-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008283/0001209191-19-008283-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008284/0001209191-19-008284-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008285/0001209191-19-008285-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008286/0001209191-19-008286-index.htm |
2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119008289/0001209191-19-008289-index.htm |
2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009410/0001209191-19-009410-index.htm |
2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009420/0001209191-19-009420-index.htm |
2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009430/0001209191-19-009430-index.htm |
2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009441/0001209191-19-009441-index.htm |
2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009449/0001209191-19-009449-index.htm |
2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009452/0001209191-19-009452-index.htm |
2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009458/0001209191-19-009458-index.htm |
2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009463/0001209191-19-009463-index.htm |
2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009469/0001209191-19-009469-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119021358/0001209191-19-021358-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119021361/0001209191-19-021361-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119021363/0001209191-19-021363-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119021365/0001209191-19-021365-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119021368/0001209191-19-021368-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119021370/0001209191-19-021370-index.htm |
2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119033844/0001209191-19-033844-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119036209/0001209191-19-036209-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119036213/0001209191-19-036213-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119036216/0001209191-19-036216-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119036219/0001209191-19-036219-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119036222/0001209191-19-036222-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119036226/0001209191-19-036226-index.htm |
2019-08-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119047753/0001209191-19-047753-index.htm |
2019-09-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119050863/0001209191-19-050863-index.htm |
2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119050926/0001209191-19-050926-index.htm |
2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119050928/0001209191-19-050928-index.htm |
2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119050930/0001209191-19-050930-index.htm |
2019-12-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919119062303/0001209191-19-062303-index.htm |
2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120000367/0001209191-20-000367-index.htm |
2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010512/0001209191-20-010512-index.htm |
2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010515/0001209191-20-010515-index.htm |
2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010517/0001209191-20-010517-index.htm |
2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010519/0001209191-20-010519-index.htm |
2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010521/0001209191-20-010521-index.htm |
2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120037633/0001209191-20-037633-index.htm |
2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120037635/0001209191-20-037635-index.htm |
2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120037638/0001209191-20-037638-index.htm |
2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120037640/0001209191-20-037640-index.htm |
2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120037644/0001209191-20-037644-index.htm |
2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120037679/0001209191-20-037679-index.htm |
2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120038515/0001209191-20-038515-index.htm |
2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120054839/0001209191-20-054839-index.htm |
2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120054841/0001209191-20-054841-index.htm |
2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1728117/000120919120054842/0001209191-20-054842-index.htm |
2019-02-05 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1728117/000135445719000056/0001354457-19-000056-index.htm |
2019-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459019007200/0001564590-19-007200-index.htm |
2019-03-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459019009018/0001564590-19-009018-index.htm |
2019-03-22 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1728117/000156459019009031/0001564590-19-009031-index.htm |
2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1728117/000156459019014266/0001564590-19-014266-index.htm |
2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1728117/000156459019014288/0001564590-19-014288-index.htm |
2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459019015682/0001564590-19-015682-index.htm |
2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459019018969/0001564590-19-018969-index.htm |
2019-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1728117/000156459019018973/0001564590-19-018973-index.htm |
2019-05-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459019020809/0001564590-19-020809-index.htm |
2019-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459019022252/0001564590-19-022252-index.htm |
2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459019030778/0001564590-19-030778-index.htm |
2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1728117/000156459019030814/0001564590-19-030814-index.htm |
2019-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459019034638/0001564590-19-034638-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459019042910/0001564590-19-042910-index.htm |
2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1728117/000156459019042943/0001564590-19-042943-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459020000961/0001564590-20-000961-index.htm |
2020-02-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1728117/000156459020004052/0001564590-20-004052-index.htm |
2020-02-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1728117/000156459020004054/0001564590-20-004054-index.htm |
2020-03-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459020012321/0001564590-20-012321-index.htm |
2020-03-24 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1728117/000156459020012323/0001564590-20-012323-index.htm |
2020-04-10 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1728117/000156459020016262/0001564590-20-016262-index.htm |
2020-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1728117/000156459020018824/0001564590-20-018824-index.htm |
2020-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1728117/000156459020018829/0001564590-20-018829-index.htm |
2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459020024672/0001564590-20-024672-index.htm |
2020-05-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1728117/000156459020024690/0001564590-20-024690-index.htm |
2020-05-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1728117/000156459020026001/0001564590-20-026001-index.htm |
2020-05-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1728117/000156459020026003/0001564590-20-026003-index.htm |
2020-05-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1728117/000156459020026204/0001564590-20-026204-index.htm |
2020-05-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1728117/000156459020026207/0001564590-20-026207-index.htm |
2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459020026546/0001564590-20-026546-index.htm |
2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459020029809/0001564590-20-029809-index.htm |
2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459020031695/0001564590-20-031695-index.htm |
2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459020039333/0001564590-20-039333-index.htm |
2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1728117/000156459020039341/0001564590-20-039341-index.htm |
2020-10-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1728117/000156459020046250/0001564590-20-046250-index.htm |
2019-02-07 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1728117/999999999519000123/9999999995-19-000123-index.htm |
2019-02-08 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1728117/999999999719000156/9999999997-19-000156-index.htm |
Gossamer Bio, Inc (GOSS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gossamer Bio, Inc (GOSS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1105%Institutional Ownership: 8507%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-12-27 | Jakob Dupont | Chief Medical Officer | Sell | 1,994.00 | 15.81 | 31,534.11 | 0.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119062303/0001209191-19-062303-index.htm |
2019-12-30 | Jakob Dupont | Chief Medical Officer | Sell | 40,000.00 | 15.00 | 600,004.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119062303/0001209191-19-062303-index.htm |
2019-05-30 | Bryan Giraudo | Chief Financial Officer | Buy | 1,000.00 | 18.70 | 18,700.00 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119033844/0001209191-19-033844-index.htm |
2019-08-29 | Luisa Salter-Cid | Chief Scientific Officer | Sell | 26,252.00 | 20.09 | 527,318.67 | 124,056.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119047753/0001209191-19-047753-index.htm |
2019-08-28 | Luisa Salter-Cid | Chief Scientific Officer | Sell | 23,748.00 | 19.65 | 466,724.19 | 150,308.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119047753/0001209191-19-047753-index.htm |
2020-02-14 | Luisa Salter-Cid | Chief Scientific Officer | Buy | 46,500.00 | 166,556.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010519/0001209191-20-010519-index.htm | ||
2020-02-14 | Sheila Gujrathi | President & CEO | Buy | 189,500.00 | 189,500.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010512/0001209191-20-010512-index.htm | ||
2019-12-27 | Jakob Dupont | Chief Medical Officer | Buy | 1,994.00 | 10.71 | 21,355.74 | 1,994.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119062303/0001209191-19-062303-index.htm |
2019-09-26 | Bryan Giraudo | Chief Financial Officer | Buy | 1,121.00 | 16.78 | 18,810.16 | 2,121.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119050863/0001209191-19-050863-index.htm |
2019-02-12 | Bryan Giraudo | Chief Financial Officer | Buy | 6,000.00 | 16.00 | 96,000.00 | 23,879.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009430/0001209191-19-009430-index.htm |
2019-09-27 | Faheem Hasnain | Director | Buy | 10,000.00 | 16.80 | 167,980.00 | 3,382,109.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119050928/0001209191-19-050928-index.htm |
2020-10-14 | Faheem Hasnain | Director | Buy | 96,520.00 | 10.36 | 999,995.46 | 3,478,629.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919120054841/0001209191-20-054841-index.htm |
2019-12-30 | Jakob Dupont | Chief Medical Officer | Buy | 40,000.00 | 10.71 | 428,400.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119062303/0001209191-19-062303-index.htm |
2019-09-27 | Sheila Gujrathi | President & CEO | Buy | 10,000.00 | 16.80 | 167,980.00 | 4,048,242.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119050926/0001209191-19-050926-index.htm |
2020-06-23 | Bryan Giraudo | Chief Financial Officer | Buy | 2,000.00 | 12.96 | 25,922.40 | 4,121.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919120038515/0001209191-20-038515-index.htm |
2019-09-27 | Waage Christian | EVP & General Counsel | Buy | 1,000.00 | 16.65 | 16,654.20 | 4,454.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119050930/0001209191-19-050930-index.htm |
2020-02-14 | Jakob Dupont | Chief Medical Officer | Buy | 46,500.00 | 46,500.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010521/0001209191-20-010521-index.htm | ||
2019-02-12 | Waage Christian | EVP & General Counsel | Buy | 1,550.00 | 16.00 | 24,800.00 | 501,498.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009441/0001209191-19-009441-index.htm |
2020-02-14 | Waage Christian | EVP & General Counsel | Buy | 46,500.00 | 547,998.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010517/0001209191-20-010517-index.htm | ||
2019-09-20 | Omega Fund V, L.P. | 10% Share Holder | Sell | 183,607.00 | 21.96 | 4,032,560.54 | 6,553,416.00 | https://www.sec.gov/Archives/edgar/data/1728117/000089924319024045/0000899243-19-024045-index.htm |
2019-09-18 | Omega Fund V, L.P. | 10% Share Holder | Sell | 45,600.00 | 21.88 | 997,636.80 | 6,737,023.00 | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023857/0000899243-19-023857-index.htm |
2019-09-17 | Omega Fund V, L.P. | 10% Share Holder | Sell | 23,400.00 | 21.62 | 505,791.00 | 6,782,623.00 | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023857/0000899243-19-023857-index.htm |
2019-09-16 | Omega Fund V, L.P. | 10% Share Holder | Sell | 13,213.00 | 21.52 | 284,330.55 | 6,806,023.00 | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023857/0000899243-19-023857-index.htm |
2019-09-11 | Omega Fund V, L.P. | 10% Share Holder | Sell | 80,403.00 | 21.31 | 1,713,629.14 | 6,819,236.00 | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023516/0000899243-19-023516-index.htm |
2019-09-10 | Omega Fund V, L.P. | 10% Share Holder | Sell | 32,373.00 | 21.00 | 679,865.37 | 6,899,639.00 | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023516/0000899243-19-023516-index.htm |
2019-09-06 | Omega Fund V, L.P. | 10% Share Holder | Sell | 8,700.00 | 21.51 | 187,103.07 | 6,932,012.00 | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023148/0000899243-19-023148-index.htm |
2019-09-05 | Omega Fund V, L.P. | 10% Share Holder | Sell | 12,704.00 | 21.60 | 274,434.35 | 6,940,712.00 | https://www.sec.gov/Archives/edgar/data/1728117/000089924319023148/0000899243-19-023148-index.htm |
2020-10-14 | Waage Christian | EVP & General Counsel | Buy | 2,500.00 | 9.53 | 23,818.00 | 6,954.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919120054842/0001209191-20-054842-index.htm |
2020-02-14 | Bryan Giraudo | Chief Financial Officer | Buy | 46,500.00 | 70,379.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919120010515/0001209191-20-010515-index.htm | ||
2020-10-14 | Bryan Giraudo | Chief Financial Officer | Buy | 3,000.00 | 10.01 | 30,036.00 | 7,121.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919120054839/0001209191-20-054839-index.htm |
2019-02-12 | Russell J. Cox | Director | Buy | 7,200.00 | 16.00 | 115,200.00 | 7,200.00 | https://www.sec.gov/Archives/edgar/data/1728117/000120919119009452/0001209191-19-009452-index.htm |